KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $8,812,000 | -12.3% | 85,000 | -33.6% | 0.55% | -17.4% |
| Q1 2017 | $10,047,000 | +75.0% | 128,000 | 0.0% | 0.66% | +78.3% |
| Q4 2016 | $5,740,000 | -30.9% | 128,000 | -13.9% | 0.37% | -26.4% |
| Q3 2016 | $8,301,000 | +11.7% | 148,600 | 0.0% | 0.51% | +11.4% |
| Q2 2016 | $7,430,000 | +8.9% | 148,600 | 0.0% | 0.46% | +19.4% |
| Q1 2016 | $6,822,000 | -25.5% | 148,600 | 0.0% | 0.38% | -16.8% |
| Q4 2015 | $9,157,000 | +17.5% | 148,600 | +6.1% | 0.46% | +1.1% |
| Q3 2015 | $7,795,000 | – | 140,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |